Insulin resistance treatment drugs herceptin,type 1 diabetes effects on glucose metabolism questions,diabetes type 2 meal plans free 5.0 - New On 2016

Science, Technology and Medicine open access publisher.Publish, read and share novel research. Myocardial Insulin Resistance: An Overview of Its Causes, Effects, and Potential TherapyEugene F. Hispanic youth were especially vulnerable but virtually all kids have been affected by this rapid escalation in diabetes. Juvenile diabetes or insulin-dependent diabetes mellitus (IDDM) is an autoimmune-related disease usually striking between the ages of 5 and 20 years in which patients do not produce enough insulin. Diabetes or diabetes mellitus as it’s formally known in medical terms Hoever there are often differences in how rapidly symptoms show up. Acanthosis nigricans: A skin condition characterized by dark thickened velvety patches, especially in the folds of skin in the axilla (armpit), groin and back of the neck. Polycystic Ovarian Syndrome (PCOS) is the most common cause of infertility that affects women in their childbearing years. If you have PCOS and are experiencing infertility, there are many treatments available to you. Gonadotropins are medications injected to increase the amount of Follicle Stimulating Hormone (FSH) in your body. PCOS is a common condition for many women in their childbearing years who are experiencing infertility. Welcome to HRC FertilityHRC Fertility is one of the largest providers of advanced fertility treatments in the U.S.
The proposed mechanism for intrahepatic lipid accumulation induced stimulation of -oxidation and ROS generation.
Proposed mechanism for renin-angiotensin system over-activation induced insulin resistance. A simplified illustration to demonstrate the effects of adipocytokines on tissue insulin sensitivity and inflammation.8. Phosphoric acid: It Autoimmune Disease Diabetes Mellitus Type 1 Cure helps in improving in low- or middle-income countries. Some of the effects of the disease increase the risk of foot problems and also increase the likelihood of complications.
Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management. Regular care from a podiatrist (a doctor specializing in foot care) such as having toenails cut and calluses removed may also be helpful.
Always let them know if there is blood in your urine if you experience pain or burning when urinating or if you continually have the urge to go after completely emptying your bladder. Caused by an imbalance in hormones, PCOS can have several alarming side effects for the women who have it. Usually, the doctor will see tiny benign cysts that form on the ovaries, often in a “string of pearls” formation. Knowing exactly when you ovulate is critical to getting pregnant when you are trying to conceive.
From changes in lifestyle to fertility drugs, there are many things a woman with PCOS can do to combat her condition and give her body the chance to get pregnant. While PCOS is a concern, there are many treatment options available to you that include natural lifestyle changes to simple pill prescription to complex assisted reproduction technologies.
High fructose diets promote hepatic de novo lipogenesis and lipid accumulation and reduce extra-hepatic VLDL-triglyceride clearance. ROS induced increases in cytokine (TNF and possibly other cytokines) expression and synthesis activates JNK which phosphorylates IRS-1 (insulin receptor substrate) at the serine307 residue.
Cytokines from macrophages and myocytes activate their receptors and associated signalling pathways to increase serine (inhibitory) phosphorylation of IRS-1. Angiotensin II activates NADPH oxidase to generate reactive oxygen species (ROS) which activate the translocation of NFB to the nucleus.
Effects of myocardial insulin resistance on myocardial metabolism, mechanical function and tolerance to ischaemia and reperfusion8.1. Donner[1] Heart Foundation Research Center, Griffith Health Institute, School of Medical Science, Griffith University, Gold Coast, Queensland, Australia1.
Eating Out With Diabetes Type 2 Kansas Overland Park type 2 Diagnosed 9-12 years after they develop the condition HgbA1C 6-7% needs monotherapy Choices are: thiazolidinedione metformi Using insulin Usually will meet patient resistance May benefit from a 7 Cardiac ri 50% of those with Type 2 Diabetes Mellitus have hypertension Severe hypoglycemia occurs when blood sugar gets so low a patient needs assistance and may result in dizziness or mental confusion injury car accident coma or rarely even Limited assets for medica Diabetes Nursing Care A How many test results will the meter’s memory hold and does it have the capability of averaging results for a designated time period? Type 2 diabetes symptoms may include one or more of the following Pediatric Blood (Sugar) Glucose Test.
There’s no cure for diabetes so treatment aims to keep your blood glucose levels as ormal as possible and to control your symptoms to prevent health problems developing later in life. Type 1 diabetes vomiting and diarrhea ak anchorage diabetes mellitus happens when the part of the pancreas that makes insulin is destroyed by that person’s own immune system.
The major risk factors for cardiovascular disease that you can do something about are cigarette smoking high blood pressure high blood cholesterol overweight and physical inactivity. It can occur with endocrine diseases such as Cushing disease, tumors of the pituitary, and diabetes mellitus.
For women with PCOS, identifying this time is difficult since it can happen at any time, or in some cases, not at all. If you are overweight as a result of PCOS, you need to begin a regiment to lose the weight. Gonadotropins will help a mature egg grow, with doctors closely monitoring the progress with ultrasounds and blood tests.If you are close to ovulating, you may be injected with Human Chorionic Gonadotropin (HCG), which triggers ovulation in 36 hours.
The associated hypertriglyceridaemia promotes adipose tissue expansion (obesity) and muscle lipid accumulation which induces insulin resistance. This inhibitory phosphorylation of IRS-1 prevents its tyrosine phosphorylation by the insulin receptor and interferes with the normal insulin signalling cascade (Illustration modified from review by Rutledge and Adeli [22].4. Long chain acetyl CoA not oxidised can be used in non-oxidative pathways with the generation of triglycerides, diacylglycerol (DAG) and ceramide. IL-6 is known to activate the STAT3-SOCS3 pathways while TNF activates JNK to phosphorylate IRS-1.6. IntroductionNormal insulin sensitivity is essential for the maintenance of normal circulating carbohydrate and lipid levels and their metabolism.
Click here to find useful information about healthy lifestyles and risk factors for heart attack stroke diabetes and heart failure.
It’s extremely important to start treating diabetes causes renal failure naperville illinois yourself the moment you realize you have xtrasize diabetes what is insulin therapy for type 2 diabetes mi lansing davenport iowa hypoglycemia.
It is common in people who have insulin resistance -- whose body is not responding correctly to the insulin that they make in their pancreas. The good news is that there are many treatments available to women with PCOS that will help manage their symptoms and get pregnant. Some of the symptoms that women can experience include acne, weight gain, abnormal facial hair growth and irregular periods. For some women with PCOS, ovulation stops because the ovaries and sometimes the adrenal glands begin making more than the normal amount of male hormone androgens, which are a type of hormone a lot like testosterone.
This will increase the body’s response to insulin, decrease androgen production, and reduce symptoms of the condition. Estimates say that the drug can stimulate ovulation 80 percent of the time with relatively few side effects for the women who are taking it. This allows you to easily time when to have intercourse or when to have Intrauterine Insemination (IUI).
Not only will these treatments help reduce symptoms and prevent additional health conditions, such as diabetes and heart disease, but they also will help you get your body ready to start your family. The role of free fatty acids and intracellular lipid accumulation in insulin resistance4.1.
The binding of these cytokines to their sarcolemmal receptors induce serine kinases and SOC3 which inhibits IRS-1 tyrosine phosphorylation, insulin signalling and GLUT4 translocation.7.
In healthy individuals elevated blood glucose levels stimulate the pancreas to release insulin which lowers blood glucose levels by stimulating glucose uptake and metabolism in muscle, adipose tissue and several other insulin sensitive organs.
During an episode of dry mouth Eating Out With Diabetes Type 2 Kansas Overland Park at night eat the gum for a minute.
Up to 2.6 million people in the UK have diabetes with half a million estimated to be unaware of their condition. This implies that risk factors for beta cell autoimmunity and type 1 diabetes must be operative in infancy.
Acanthosis nigricans also occurs with underlying malignancies (especially carcinomas of the vicera), administration of certain drugs, and as a genetic disorder inherited in an autosomal dominant manner. More severe cases can experience insulin resistance where the body does not respond to insulin, raising the woman’s blood sugar levels.
There is no known cause for PCOS, but researchers suspect that genetics play a role in the cause of the disease. Weight loss will bring your hormones back into balance, which will help you to have regular periods so you can predict ovulation and make conception easier. The fertilized egg, or embryo, is transferred to your uterus, where it will implant and grow into pregnancy.
Blood glucose increases are not only countered by increased tissue glucose uptake but also by insulin induced suppression of hepatic glycogenolysis and gluconeogenesis.
Type 1 diabetes mellitus susceptibility and genetic risk determined on the basis of DNA analysis. A good snack will range from about 100 to 200 calories and consist of 15 to 30 grams of carbohydrats. Type 1 diabetes is a lifelong (chronic) disease in which there is a high level of sugar (glucose) in the blood. Insulin is a hormone that helps turn glucose from for the body is not from sugar at all, but from foods such as cereal, bread, rice, pasta, and other grains. Besides its effects on blood glucose, insulin also affects circulating lipid levels by reducing hepatic very low density lipoprotein cholesterol (VLDL-cholesterol) formation from free fatty acids (FFAs). This is primarily due to the reduced free fatty acid supply to the liver caused by insulin induced suppression of lipogenesis in adipose tissue [1]. The majority of your diet should consist of carbohydrates (like whole grain bread, rice, cereal) and fruits and vegetables. In addition to its effects on lipogenesis, insulin also reduces lipolysis in adipose tissue by inhibiting hormone sensitive lipase. Diabetes and the foods you eat When you eat or drink, much of your food is broken down into a simple sugar called glucose. The latter hydrolyses adipocyte triglycerides to release free fatty acids and glycerol into the circulation. When delivered acutely, insulin inhibits fatty acid synthase while chronic hyperinsulinaemia (as occurs in insulin resistance) may induce fatty acid synthase activity and increase fatty acid synthesis [2]. The net effect of elevated insulin in normal healthy individuals is to reduce circulating glucose and free fatty acid levels. When an individual becomes insulin resistant, control of circulating lipid and blood glucose levels is compromised. Insulin resistance ensues when normal physiological concentrations of insulin are unable to induce effective uptake of glucose by insulin sensitive tissue. However, dietitians say the researchers have jumped to conclusions and argue there is no proof that eating lots of white rice actually causes T2 diabetes. As a compensatory mechanism aimed at maintaining euglycaemia, pancreatic insulin secretion increases leading to a state of hyperinsulinaemia. If the elevated insulin levels are inadequate to fully compensate for the insulin insensitivity glucose intolerance ensues.
The degree of glucose intolerance in insulin resistant individuals is thus dependent on the extent of the loss of the in vivo function of insulin, and the ability of the pancreas to adjust for this by secreting more insulin [3, 4]. Once elevated circulating levels of insulin are no longer able to maintain euglycaemia, and glucose levels deviate beyond normal physiological ranges an individual is considered to be frankly diabetic. Myocardial insulin resistance translates to compromised intracellular insulin signalling and reduced glucose oxidation rates in animal models of obesity [5] and adversely affects myocardial mechanical function and tolerance to ischaemia and reperfusion.
In this chapter we will review the mechanisms implicated in the aetiology of insulin resistance (skeletal and heart muscle) and discuss the effects of insulin resistance on cardiac metabolism, mechanical function and tolerance to ischaemia and reperfusion. We will also briefly review therapies used to prevent or counter insulin resistance and its associated adverse effects on the cardiovascular system.2. Myocardial insulin signallingInsulin induced activation of the insulin receptor (IR) invokes a cascade of events which ultimately enhances myocardial glucose uptake and metabolism. Insulin binding to its receptor results in autophosphorylation and activation of the insulin receptors (IRs) intrinsic tyrosine kinases.


Following phosphorylation the insulin receptor phosphorylates insulin receptor substrate (IRS) [6] which subsequently associates with phosphoinositide 3-kinase (PI3K) via its p85 subunit [7, 8].
Besides facilitating glucose uptake via GLUT4, insulin stimulation also increases glycolytic flux rates through activation of phosphofructosekinase 2 (PFK-2) which promotes the production of fructose-2,6-bisphosphate from fructose-6-phosphate [16-18]. Fructose-2,6-bisphosphate stimulates PFK-1 activity, which will also enhance glycolysis (see review by Hue et al. This suppression is most likely due to the effects of by-products of elevated glucose oxidation on malonyl-CoA levels [20]. The role of obesity or a high fructose diet in the aetiology of insulin resistanceInsulin resistance is strongly associated with both obesity and the consumption of high fructose containing diets [21-25]. Although not all obese individual are insulin resistant, there is a strong association between obesity and insulin resistance [21, 25]. Adipose tissue is not only a storage organ but also a metabolically active organ synthesising and secreting a large range of substances that include fatty acids, pro-inflammatory cytokines, angiotensin II, leptin, resistin, visfatin and other adipocytokines [26] that can all influence tissue metabolism. Obesity and high fructose diets both induce increases in: 1) circulating FFAs [27, 28], 2) renin-angiotensin system (RAS) activity [29, 30], and 3) inflammation (caused by tissue and macrophage derived pro-inflammatory cytokines) [31] that are all associated with, and implicated in insulin resistance.
Besides the negative impact of obesity on circulating lipids, recent studies provide convincing evidence for a role for high fructose diets in dyslipidaemia and insulin resistance [24, 27, 32]. These lipid profile altering effects of high fructose diets are primarily caused by fructose induced alterations in hepatic lipid metabolism [22-24]. Hepatic fructose metabolism differs significantly from glucose metabolism with fructose being a lipogenic sugar that promotes the deposition of triglycerides in adipose tissue and ectopic organs such as the liver and muscle. This tissue triglyceride accumulation eventually contributes to dyslipidaemia and insulin resistance [22, 27, 33].Increasing dietary fructose consumption increases plasma triglyceride levels through stimulation of hepatic lipogenesis [34] and decreased VLDL-triglyceride removal from the plasma by adipose tissue [35].
Fructose evidently also activates genes involved in hepatic de novo lipogenesis [36, 37] which causes increased hepatic fatty acid generation. These fatty acids are incorporated into hepatic triglycerides which promotes VLDL-triglyceride synthesis and release from the liver (Figure 1)[38]. A recent review highlights the possible effects of high fructose diets on hepatic insulin resistance [22]. These authors propose that high fructose diets promote hepatic inflammation by increasing fatty acid -oxidation (secondary to hepatic lipid accumulation) which generates peroxidation products that stimulate inhibitor of nuclear factor kappa-B kinase subunit beta (IKK) and activate nuclear factor kappa-light-chain-enhancer of activated B cells (NFB). The NFB then enters the nucleus and induces the transcription of genes that encode for pro-inflammatory cytokines that include tumour necrosis factor alpha (TNF) and interleukin-6 (IL-6). These cytokines potentially activate c-Jun N-terminal kinase-1 (JNK-1) which will increase inhibitory serine307 phosphorylation of IRS-1 and contribute to hepatic insulin resistance [22] (Figure 2).
Because of its lipogenic effects, fructose causes more marked changes in 24 hour lipid profiles than does the consumption of glucose while also favouring visceral rather than subcutaneous fat deposition [33]. This fat deposition pattern differs from that of glucose which promotes subcutaneous adipose tissue deposition rather that visceral fat deposition in men [39]. In rodents, a high fructose diet increases intrahepatic fat content and serum VLDL-triglyceride concentrations within 6 weeks of feeding. In the same study intramuscular fat content was increased within 3 months of initiating the high fructose feeding with these changes being closely followed by hepatic and muscle insulin resistance [32].
Another animal based study supports a role for high fructose diets in increased hepatic VLDL-triglyceride secretion [40]. The associated hypertriglyceridaemia promotes adipose tissue expansion (obesity) and muscle lipid accumulation which induces insulin resistance.Since high fructose diets are often also associated with obesity, it is difficult to differentiate between the effects of the changes in dietary fructose content and the effects of obesity on tissue insulin sensitivity.
Data from studies demonstrating that some individuals are obese but metabolically healthy [42] and metabolic syndrome appears to be more closely linked to intrahepatic fat content than obesity per se [1, 41, 43], suggests that hepatic lipid metabolism and circulating lipid levels play a critical role in the induction of insulin resistance in response to obesity and high fructose diets. Tappy and co-workers [23, 24] recently proposed that fructose increases hepatic de novo lipogenesis which leads to intrahepatic lipid deposition, hepatic insulin resistance and increased VLDL-triglyceride secretion.
This potentially leads to increased visceral fat deposition while the elevated VLDL-triglyceride and inhibition of lipid oxidation (induced by fructose) may promote ectopic fat deposition in muscle with lipotoxicity leading to systemic insulin resistance (Figure 1) [22-24]Figure 2.The proposed mechanism for intrahepatic lipid accumulation induced stimulation of -oxidation and ROS generation. We will first review the evidence for a role for elevated circulating free fatty acids, and tissue triglycerides and lipid intermediates accumulation in the aetiology of insulin resistance in skeletal and heart muscle.4. The role of free fatty acids and intracellular lipid accumulation in insulin resistanceA prevalent metabolic change associated with obesity [44-49] and high fructose feeding [22-24] is the increase in the circulating free fatty acids and triglycerides.
Under conditions of over-nutrition and dyslipidaemia, not all fatty acids entering the cell are utilized for oxidative purposes.
Long chain fatty acyl-CoA accumulation provides substrates for non-oxidative processes such as triglyceride, diacylglycerol (DAG) and ceramide synthesis [50, 51]. In the myocardium lipid accumulation is a direct result of a mismatch between fatty acid uptake and oxidation by the cell [47, 52]. What is not clear is whether this accumulation is due to: 1) increased FFA uptake by the heart 2) compromised FFA oxidation, or, 3) a combination of the two. There is a strong link between increased circulating free fatty acids, myocardial triglyceride accumulation and insulin resistance. Increased circulating free fatty acids increase the expression of sarcolemmal fatty acid transporters and increases fatty acid uptake into the myocyte.
Besides its adverse effects on insulin signalling and glucose metabolism, excessive intramyocellular lipid accumulation may also have direct lipotoxic effects [50, 57]. Both altered substrate utilization and excess intramyocardial lipid accumulation which is characteristic of obesity, dyslipidaemia and insulin resistance may have serious cardiac consequences that ultimately lead to compromised cardiac metabolism, morphology and mechanical function. Lipid intermediates may adversely influence insulin signalling and contribute to insulin resistance [5, 58, 59]. The accumulation of triglycerides, diacylglycerol (DAG) and ceramide is known to activate kinases that down-regulate insulin signalling [60-62]. These kinases include JNK, IKK and protein kinase C (PKC) that is known to inhibit insulin signalling via serine phosphorylation of IRS-1 [5, 63].Ceramide accumulation occurs through de novo synthesis from saturated fatty acids [64] or hydrolysis of sphingomyelin [65]. It has been shown to cause insulin resistance by inhibiting Akt phosphorylation in skeletal muscle [66-68] and adipocytes [69] with the pharmacological inhibition of ceramide synthesis being effective in preventing lipid induced insulin resistance in rats [67, 70].Models of lipotoxicity have also demonstrated that elevated myocardial ceramide levels are associated with increases in indices of apoptosis [52, 71]. Rat neonatal cardiomyocytes incubated with physiological concentrations of palmitate have increased intracellular triglycerides, increased ceramide levels and increased indices of apoptosis [72]. The mechanism implicated in ceramide induced apoptosis may involve activation of NF?B which in turn up regulates inducible nitric oxide synthase (iNOS) expression [73]. The resulting increase in nitric oxide production [74] may cause a subsequent rise in the formation of peroxynitrite, which induces mitochondrial cytochrome C release [75] and subsequent apoptosis.
In addition, ceramide has been shown to directly induce the generation of damaging reactive oxygen species in the mitochondria [76]. Obese insulin resistant (prediabetic) Zucker rats also have elevated intramyocardial triglycerides which are accompanied by increased myocardial ceramide levels and cardiomyocyte apoptosis.
These cellular alterations are present before the onset of diabetes and cardiac dysfunction [71]. Reducing myocardial lipid levels by treating the rats with peroxisome proliferator-activated receptor gamma (PPAR) agonists lead to reduced cardiac ceramide levels and apoptosis and prevented cardiac dysfunction [71]. In a similar study, mice over-expressing cardiac specific long chain acyl-CoA synthase display high intramyocardial triglycerides and ceramide levels. These changes were accompanied by increased DNA fragmentation and cytochrome C release with the mice developing cardiac hypertrophy and left-ventricular dysfunction [52].Lipid infusion increases intracellular DAG and causes skeletal muscle insulin resistance in rodents [60]. This association between intracellular DAG levels and skeletal muscle insulin resistance has been confirmed in several rodent and human studies [77-79]. Increased muscle DAG is associated with increased activation of protein kinase C theta (PKC-) in obese and diabetic patients [80, 81].
Increased PKC- activation interferes with insulin signalling by increasing IRS-1 serine307 phosphorylation (Figure 3)[60, 81].
Accelerating fatty acid oxidation rates potentially prevents fatty acid, acetyl-CoA and subsequent DAG accumulation and may improve insulin sensitivity. Evidence for lipid accumulation in skeletal muscle insulin resistance An inverse correlation exists between intramuscular lipid content and insulin sensitivity. Measurements of insulin sensitivity (120 min euglycaemic hyperinsulinaemic clamp) in skeletal muscle from healthy subjects demonstrated that high intramuscular lipid content was associated with lower whole body insulin stimulated glucose uptake.
These subjects also exhibited elevated circulating free fatty acids, reduced tyrosine phosphorylation of the insulin receptor (IR) and lower (insulin receptor substrate) IRS-1 mediated PI3K activation during hyperinsulinaemia than subjects with low intramuscular lipids [83]. Studies comparing lean and obese individuals have made similar observations linking intracellular lipid accumulation to skeletal muscle insulin resistance [84, 85].
Boden and colleagues [86] reported a strong association between serum free fatty acid levels, intramuscular lipid content and insulin resistance after lipid injection in healthy subjects. Elevated circulating free fatty acid levels, induced by lipid injection, was associated with a gradual increase in intramuscular lipid content and a 40% increase in insulin resistance.
Both the latter lipid metabolites have been implicated in aetiology of insulin resistance through the activation of PKC, IKK and JNK.In rodent skeletal muscle, experimentally elevated circulating free fatty acids increased intracellular acetyl-CoA and DAG levels which was coupled to increased active protein kinase C (PKC) theta. These changes were accompanied by increased IRS-1 serine phosphorylation, reduced IRS-1 tyrosine phosphorylation and reduced IRS-1 associated PI3K activity [60, 88]. Evidence for lipid accumulation in cardiac muscle insulin resistance Similar associations between increased intracellular lipid accumulation and reduced insulin sensitivity have been observed in cardiac muscle from obese insulin resistant animals [47, 71, 89, 90].
In obese insulin resistant JCR:LA-cp rats, the increased supply of circulating free fatty acids was associated with a 50% increase in myocardial triglyceride content and a 50% reduction in myocardial glycolytic flux rates [89]. In humans, plasma free fatty acid levels correlate with intramyocardial triglyceride levels [91]. This association is also evident in obese [91, 92], obese glucose intolerant [93] and diabetic [93, 94] individuals. Excessive intramyocardial triglyceride accumulation precedes the development of type-2 diabetes and tends to increase linearly with the degree of systemic insulin resistance [93].
Obese insulin resistant humans do not always have elevated serum free fatty acid levels but do appear to maintain higher rates of free fatty acid uptake, utilization and subsequent oxidation than lean controls [95].5. The role of cytokines and chronic inflammation in insulin resistanceObesity and insulin resistance is associated with chronic systemic inflammation caused by activation of the intrinsic immune systems in organs and the macrophages that infiltrate them [96].
The most prominent pro-inflammatory mediators involved in this inflammation are TNF and IL-6 that originate from: 1) macrophages in adipose tissue and the liver [97], 2) the adipocytes themselves [97], and, 3) several other cytokine synthesising tissues in the body [97-99]. Elevated free fatty acids may increase pro-inflammatory cytokine expression and synthesis since studies inducing acute increases in plasma free fatty acids have observed activation of NFB in skeletal muscle in humans [79] and increases hepatic TNF, IL-1 and IL-6 and circulating monocyte chemotactic protein-1 (MCP-1) in rats [100, 101]. How elevated fatty acid cause NFB activation is unknown but may involve DAG and PKC [102] or the Toll-like receptor 4 (TLR-4) [103]. MCP-1 is also known to regulate recruitment of macrophages to sites of inflammation and may be involved in the recruitment and differentiation of monocytes to macrophages that produce pro-inflammatory cytokines in conditions such as obesity and dyslipidaemia [97, 104]. TNF causes insulin resistance by suppressing IRS-1 associated insulin signalling and glucose transport in skeletal muscle while IL-6 activates the phosphatase SHP-2 and Signal transducer and activator of transcription 3 (STAT3) causing increased expression of suppressor of cytokine signalling 3 (SOCS3) [105, 106]. Information relating to the possible role of inflammation in the aetiology of myocardial insulin resistance is limited.
A recent study however reported that high fat feeding caused increased myocardial macrophage infiltration and increased cytokine and SOCS levels in cardiomyocytes from these animals [109]. These changes were associated with reduced myocardial insulin sensitivity and glucose metabolism. The role of the Renin-Angiotensin System (RAS) in insulin resistanceThe authors [110] and others [111-115] have shown that the systemic and tissue renin-angiotensin systems (RAS) activity is increased in obesity. The role of increased RAS activity in metabolic and cardiovascular disease has been reviewed in detail [29, 116-118]. A key observation linking the RAS system to insulin resistance was made when it became apparent that hypertensive patients treated with angiotensin converting enzyme (ACE) inhibitors or angiotensin (AT) receptor blockers have a reduced risk of developing insulin resistance and type-2 diabetes when compared to patients on other conventional anti-hypertensive therapy [119, 120]. Subsequent studies have corroborated these observations with RAS inhibition improving blood glucose management [121] and lowering risk of type-2 diabetes [122].
These data provided indirect evidence to suggest that the RAS (and particularly over-activation) contributes to insulin resistance and type-2 diabetes.Several human and animal studies support a role for RAS over-activity in insulin resistance. Genetic abnormalities leading to over-activation of the RAS provides strong evidence for the involvement of the RAS in insulin resistance.
Similarly, AGTT174M polymorphisms are associated with metabolic syndrome in aboriginal Canadians [126]. As mentioned previously, pharmacological blockade of the RAS in clinical trials has provided the most compelling evidence for a role for RAS over-activity in metabolic abnormalities such as insulin resistance. The use of ACE inhibitors for antihypertensive therapy reduces the risk of developing type-2 diabetes by 14% [119]. Studies on animals support these observations with RAS inhibition improving insulin sensitivity in rat [127] and mice [128]. Genetic deletion of renin [129] or ACE [130] or one of the two AT receptors also appears to be effective in preventing or reducing insulin resistance in mice [131, 132].Besides the evidence showing that inhibition of RAS activity may improve insulin sensitivity, several studies also provide direct evidence implicating over-activation of the RAS in the aetiology of insulin resistance. Chronic angiotensin II infusion causes insulin resistance in rats [133, 134] while the TG(mREN2)27 rat which suffers from chronic systemic RAS over-activation develops muscle and systemic insulin resistance [135].
The RAS induced insulin resistance in these animals is improved by renin inhibition or angiotensin receptor blockade [135, 136].The mechanism for angiotensin II (Ang II) induced insulin resistance has received significant attention.


Ang II adversely affects glucose metabolism and decreases its uptake and utilisation by interfering with insulin signalling [137]. In L6 myocytes Ang II suppresses insulin induced phosphorylation of the tyrosine residue on IRS-1. Based on these observations it seems likely that Ang II activates NADPH oxidase and increases reactive oxygen species (ROS) generation through the angiotensin type 1 (AT1) receptor. These cytokines increase SOCS3 expression which inhibits insulin signalling (Figure 5) [140].
In rats Ang II also reduces skeletal muscle mitochondrial content (possibly through increased ROS generation) which would be expected to reduce muscle glucose utilisation [141].
Figure 5.Proposed mechanism for renin-angiotensin system over-activation induced insulin resistance. The binding of these cytokines to their sarcolemmal receptors induce serine kinases and SOC3 which inhibits IRS-1 tyrosine phosphorylation, insulin signalling and GLUT4 translocation.Adipose tissue RAS over-activity may also contribute to systemic insulin resistance since Ang II from adipose tissue contributes to circulating Ang II levels.
This was well demonstrated by a study investigating the effect of adipose tissue angiotensinogen (Agt) over-expression on systemic glucose tolerance and insulin resistance [142]. The over-expression of Agt in adipose tissue caused cardiac and skeletal insulin resistance and reduced muscle glucose uptake.7.
Besides the two pro-inflammatory cytokines discussed previously (TNF and IL-6) adipocytes secrete several well characterised adipocytokines that include: leptin, adiponectin, and resistin.
Dysregulation of the synthesis and secretion of these peptides has been associated with, and implicated in, the aetiology of metabolic diseases such as insulin resistance and type-2 diabetes. A possible role for adipokines in the regulation of myocardial metabolism only emerged recently [143-145]. Leptin is synthesised by white adipose tissue and is involved in appetite control and energy expenditure.
Although the absence of leptin leads to obesity and insulin resistance, most obese patients have elevated leptin levels but do not respond to the appetite suppressing and other effects of the peptide [146, 147].
Serum triglyceride levels and blood glucose handling also improved in women with lipodystrophy and leptin deficiency indicating that leptin may alter lipid metabolism and prevent lipotoxicity [153].
In rat adipocytes leptin reduces insulin’s’ lipogenic effect by: 1) inhibiting insulin binding to its receptor [154], 2) increasing adipose and non-adipose tissue -oxidation, and, 3) decreasing adipose tissue triglyceride content without elevating circulating free fatty acids (Figure 6) [74]. This reduction in serum fatty acid levels will also counter the effect of insulin on lipogenesis [74, 154]. The lipid lowering effects of leptin in heart muscle was demonstrated in a study where 24 hour high fat feeding of mice was associated with cardiac lipid accumulation in animals with low leptin levels but not those with high plasma leptin levels [156]. Leptin administration decreases cardiac muscle lipotoxicity in a subsequent study by this group [157].Leptin administration to the perfusate of isolated rat hearts perfused with palmitate and glucose significantly increased fatty acid oxidation and reduced intramyocardial triglyceride content without increasing cardiac work.
This was accompanied by increased myocardial oxygen consumption and reduced cardiac efficiency [143]. These animals are obese, insulin resistant and display excess intramyocardial lipid accumulation.
They are also more prone to increased cardiomyocyte apoptosis and cardiac dysfunction than their control littermates [158-162].Circulating adiponectin levels are reduced in obesity, insulin resistance and diabetes and correlate with the extent of insulin resistance and hyperinsulinaemia [163-165]. It is synthesised by adipocytes, skeletal muscle, heart muscle and endothelial cells [166] and is a key adipocytokine in the regulation of metabolism. It is considered to be an anti-diabetic, anti-inflammatory and anti-atherogenic agent with adiponectin deficient animals becoming glucose intolerant, insulin resistance and hyperleptinaemic [167, 168]. Studies utilising adiponectin replacement therapy have demonstrated its ability to decrease dyslipidaemia [169] and improve insulin sensitivity (Figure 6) [170-172].Adiponectin acts via phosphorylation of 5'adenosine monophosphate-activated protein kinase (AMPK) to influence insulin sensitivity and fatty acid and glucose utilisation [172, 173]. Its action is mediated through the AdipoR1 and AdipoR2 receptors [170] that are both expressed in cardiac tissue [174].
Resistin is secreted from white adipose tissue but is also expressed in other tissues [178]. It was given its name because it was originally shown to counter the effects of insulin by suppressing insulin signalling [179]. Over-expression of resistin is associated with dyslipidaemia and insulin resistance [180, 181] and inhibition of glucose uptake in cardiomyocytes [182]. In humans plasma resistin levels are closely correlated to insulin resistance irrespective of body weight [183]. However, these observations are not supported by two animal studies that found that resistin levels were not a good predictor of insulin resistance when corrected for body mass index (BMI) [184, 185].
In both high fat diet and genetic mutation induced obesity, resistin levels were closely associated with body weight with obese animals having significantly elevated resistin levels [179].
The exact role of resistin in insulin resistance is however poorly understood and unresolved.8. Effects of myocardial insulin resistance on myocardial metabolism, mechanical function and tolerance to ischaemia and reperfusionThe heart utilises glucose, fatty acids and lactate as fuels for the production of ATP. Cardiac metabolism is under the control of several hormones with insulin being a key regulator of glucose, fatty acid and lactate metabolism.
Myocardial metabolismThe heart is a dynamic organ, constantly requiring energy in the form of ATP in order to meet its homeostatic and contractile demands.
Although the adult heart is capable of oxidizing a variety of substrates, the majority of ATP (60-70%) generated by the heart originates from the oxidation of fatty acids [186, 187].
However, in the presence of elevated glucose and insulin levels as occurs immediately following a meal, 60-70% of ATP may be derived from glucose metabolism [188].Circulating fatty acids are taken up by the heart either in their free form (as free fatty acids (FFAs)) bound to albumin, or they can be released from the triglyceride component of chylomicrons or very-low-density-lipoproteins (VLDL) [189].
The concentration of fatty acids present in blood greatly dictates their uptake and metabolism by the heart [190].
Under normal physiological conditions, long chain fatty acids (LCFAs) are the principal fatty acids oxidized by the heart [191]. The entry of LCFAs across the sarcolemma into the cytoplasm of the cardiomyocyte occurs though passive diffusion or membrane protein mediated transport, the latter accounting for the majority of fatty acid translocation to the cytosol [192]. Once inside the cell, non-esterified LCFAs are transported via cytoplasmic heart-type FABPs through the cytoplasm to the location where they will be utilized [193-195]. LCFA-CoAs can be stored in intracellular lipid pools where they can be converted to additional lipid intermediates (triglycerides, diacylglycerol (DAG) or ceramide), or are transported to the mitochondria where they undergo ?-oxidation. Glucose enters the cardiomyocyte through either the basal uptake glucose transporter, GLUT1, or via the insulin dependent glucose transporter, GLUT4 [196]. GLUT4 is stored in cytoplasmic vesicles which are recruited to the sarcolemma in response to insulin stimulation or cardiac contraction.
Glucose itself can also induce GLUT4 translocation with this and insulin stimulated translocation determining the glucose flux rate into the cardiomyocyte [197]. Inside the cell hexokinase converts glucose to glucose-6-phosphate which can be stored as glycogen (after conversion by glycogen synthase) or it can undergo glycolysis to yield pyruvate and ATP. During adequate myocardial oxygen availability pyruvate is transported into the mitochondria via a mitochondrial monocarboxylate transporter [198] and subsequently oxidized by pyruvate dehydrogenase (PDH) to produce acetyl-CoA (reviewed by Stanley et al. During anaerobic conditions as occurs during myocardial ischaemia, pyruvate may be converted to lactate.The rate of glucose oxidation is also influenced by fatty acid ?-oxidation rates since hexokinase, PFK and PDH activity are all inhibited by various products of fatty acid metabolism (for a review see Hue and Taegtmeyer [200]). There is a delicate interplay in the utilisation of these two myocardial substrates which is intricately related to their circulating levels. Impact of myocardial insulin resistance on myocardial metabolismThe early onset of insulin resistance in obesity may be a physiological response to increased lipid availability leading to increased lipid utilisation and a reciprocal reduction in glucose metabolism. Chronic dysregulation of glucose uptake and metabolism by dyslipidaemia and inflammation may however induce pathological changes in cardiac metabolism that compromise cardiac morphology and mechanical function.
With myocardial insulin resistance, fatty acid oxidation rates are normal or elevated, while glucose oxidation rates are normally reduced both in the presence or absence of insulin stimulation [5, 44, 45, 203-205]. Although a limited number of studies have reported similar myocardial fatty acid and glucose oxidation rates in obese, insulin resistant animals when compared to lean controls, they have all found that insulin stimulated myocardial glycolytic flux rates remain suppressed with insulin resistance [89, 206]. In humans similar increases in myocardial fatty acid metabolism were reported in obese men and women. Gender however also played and important role in determining the impact of obesity of glucose and fatty acid uptake and utilization [207].
Women were less prone to obesity induced dysregulation of myocardial metabolism than their obese male counterparts.
Effect of insulin resistance on cardiac mechanical functionIncreased lipid uptake and oxidation as seen with insulin resistance potentially leads to cellular lipid intermediate accumulation, excessive mitochondrial or peroxisomal ROS generation and functional derangement in the heart [71]. This is well demonstrated by a study showing that cardiac specific PPAR over-expression which increases cardiac lipid oxidation causes metabolic derangements and leads to adverse structural and function changes in the heart [208] Pre-diabetic (insulin resistant) obese Zucker rats display cardiac dysfunction [47]. These changes were also associated with systolic dysfunction when compared to lean insulin sensitive littermates [45]. Although genetic models of obesity do not accurately resemble the phenotype of human obesity, the recent development of a number of models of diet-induced obesity have contributed to a better understanding of the impact of obesity and insulin resistance on myocardial function. The authors and other research groups have however also shown that rodent models of diet-induced obesity with insulin resistance have either normal [90, 203, 205, 209, 210] or compromised [110, 203, 204, 211, 212] cardiac mechanical function. It is currently not possible to conclusively attribute the cardiac dysfunction reported in these studies to myocardial insulin resistance since there are several studies that have reported normal cardiac function in animal models with insulin resistance [90, 203, 205, 209, 210]. Reduced cardiac efficiency possibly contributes to cardiac dysfunction in obesity, insulin resistance and diabetes [44, 45, 213]. Animals [44, 45, 162, 213] and humans [95] that are obese and insulin resistant or diabetic have increased myocardial oxygen consumption which reflects a decreased cardiac efficiency as determined by the myocardial work to myocardial oxygen consumption ratio [214]. Mitochondria isolated from obese insulin resistant mice have reduced oxidative capacity, and display fatty acid induced uncoupling of mitochondrial oxygen consumption and ATP production which is evident from the reduced ATP-to-O ratios [162, 213]. This data from human and rodent studies also implicate impaired mitochondrial energetics in the cardiac dysfunction associated with obesity and insulin resistance. Ischaemia essentially disrupts the tightly coupled ATP breakdown and re-synthesis equilibrium that exists during normoxia and leads to an ATP deficit. Cellular ATP becomes depleted with the extent of this depletion being dependent on the duration and severity of ischaemia [216]. Although oxidative metabolism is reduced during ischaemia, reperfusion after ischaemia is associated with an initial increase in glycolytic flux rate which quickly declines to normal levels [217]. Despite glycolysis only accountings for a small amount of the total ATP production under aerobic conditions, glycolytically generated ATP becomes invaluable in the maintenance of cellular ion pump function and ion homeostasis and the reduction of myocardial damage during mild ischaemia [218]. While glycolytically produced ATP may aid in maintaining ion homeostasis during ischaemia, it is insufficient for the maintenance of myocardial contractile function [218]. Under conditions of severe ischaemia in the absence of a glucose and oxygen, myocardial glycogen stores undergoing glycolysis do not only contribute to the ATP synthesised, but greatly increase cytosolic proton accumulation and a decline in intracellular pH [219].
Despite its potential adverse effect on pH, elevated glycogen levels at the onset of myocardial ischaemia may be important in maintaining tissue ATP levels since it has been associated with improved functional recovery after ischaemia [220]. Despite myocardial ischaemia decreasing mitochondrial substrate oxidation, fatty acid oxidation predominates during ischaemia and subsequent early reperfusion [221].
During early ischaemia there is a transient increase in anaerobic glycolysis while glucose oxidation decreases [199, 221-224].
Under these conditions normal or increased glucose uptake (under the influence of insulin) may be important for the delivery of glycolytic ATP to maintain ion homeostasis. Although fatty acids are predominantly oxidized by the ischaemic heart, the preference for fatty acid oxidation as occurs under dyslipidaemic conditions also has adverse effects on the ischaemic and reperfused heart. The mitochondrion generates 12% less ATP per oxygen molecule through the oxidation of fatty acids compared to glucose oxidation during normoxia [187]. Increased fatty acid oxidation consequently reduces cardiac efficiency during ischaemia and subsequent reperfusion. During reperfusion the glycolytic flux rate exceeds glucose oxidation rates which remains suppressed due to increased fatty acid oxidation during reperfusion [224, 227]. This fatty acid induced uncoupling of glucose oxidation from glycolysis results in an accumulation of hydrogen ions which can damage the heart and affect post ischaemic function [199, 228-230]. These detrimental effects of increased fatty acid -oxidation during both ischaemia and reperfusion would be expected to be pronounced in dyslipidaemia (as occurs in obesity and high fructose feeding) and insulin resistance and exacerbate ischaemic injury. Pharmacological inhibition of myocardial fatty acid oxidation prior to the onset of, or during reperfusion results in increased glucose oxidation and improved cardiac functional recovery following the ischaemic episode [224, 227]. Hearts from prediabetic obese Zucker rats have reduced GLUT4 expression, reduced glucose uptake and larger reductions in tissue ATP levels during low-flow ischaemia. These changes are associated with poorer post-ischaemic functional recoveries when compared to their lean control littermates [231].




January birthstone poem
Type 2 diabetes symptoms stomach pain gas
Diabetes free org video antichrist
Blood sugar levels for diabetes


Comments

  1. anxel

    Associated with the high chlorogenic and a pair of-3 tablespoons of heavy.

    16.04.2015

  2. Ramin62

    Going by way of hadza who're capable of eat more than 4kkalories pet news.

    16.04.2015

  3. SOSO

    Insidiously insulin resistance treatment drugs herceptin contains sugar and exhibited an identical effect in the regulation of glucose metabolism, such as HbA1c.

    16.04.2015

  4. Azeri_Sahmar

    Amounts, a number of jarred sauces last.

    16.04.2015